Minimal Treatment of Low-Risk, Pediatric Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the Children's Oncology Group [Pediatric Oncology]
Conclusion
Some 75% of highly selected pediatric patients with LPHL may be spared chemotherapy after surgical resection alone. Pediatric LPHL has excellent EFS with chemotherapy that is less intensive than standard regimens; > 90% of patients can avoid radiation therapy. The salvage rate for the few relapses is high, with 100% survival overall.
Source: Journal of Clinical Oncology - Category: Cancer & Oncology Authors: Appel, Chen, Buxton, Hutchison, Hodgson, Ehrlich, Constine, Schwartz Tags: Combined Modality, Hodgkin's Disease Pediatric Oncology Source Type: research
More News: Cancer & Oncology | Chemotherapy | Children | Hodgkin's Disease | Lymphoma | Pediatrics | Prednisone | Radiation Therapy | Study